MedCan
MedCan is a privately held South African cultivator that grows pharmaceutical-grade, high-THC medical cannabis indoors in Isando and exports it to licensed pharmaceutical distributors in the United Kingdom under its Isando TS 19 and Isando TS 24 product lines.
- Company typePrivate
- Founded2015
- HeadquartersJohannesburg, South Africa
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What MedCan does
MedCan is a privately held, South African pharmaceutical-grade medical cannabis cultivator headquartered in Isando, Johannesburg. Founded in 2015 and licensed by SAHPRA in 2020, the company operates a fully indoor, purpose-built facility converted from a former beer warehouse, with integrated propagation, cultivation, harvest, post-harvest, and sterile operations areas. It is GACP and GMP certified and was the first South African company granted a license to commercially export high-THC cannabis flowers, with the United Kingdom as its primary destination market.
The company's product portfolio is concentrated in two SKUs under the Isando sub-brand: Isando TS 19 (19% THC) and Isando TS 24 (24% THC, <1% CBD, >1% CBG), both derived from the proprietary Tokoloshe Sherbet strain lineage (Jack Herer crossed with Ace of Spades and back-crossed with Biker Kush V2). Cultivation relies on coco perlite growing media with organic amendments, precision environmental controls (16-hour minimum vegetative light cycle, 16°C drying, 60-65% RH), and a documented in-house pheno-hunting process. Sustainability infrastructure includes 32,963 liters of annual rainwater harvesting, 90% water recapture, and solar power offsetting more than 98 tons of CO2 per year.
MedCan operates a B2B go-to-market, selling directly to licensed pharmaceutical distributors and medical cannabis product manufacturers in the UK. Pricing is undisclosed and determined through commercial agreements; no contracts, revenue figures, or investor backing are public. The company is founder-owned and bootstrapped, with a leadership team spanning pharmacy, law, engineering, property development, and diamond trading, plus a Head of Cultivation holding a BSc in Botany.
MedCan firmographics
Firmographics- Name
- MedCan
- Legal name
- MEDCAN
- Website
- https://medcan.co.za
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MedCan is a privately held South African cultivator that grows pharmaceutical-grade, high-THC medical cannabis indoors in Isando and exports it to licensed pharmaceutical distributors in the United Kingdom under its Isando TS 19 and Isando TS 24 product lines.
- Ownership category
- akta.pro rank
MedCan industry classification
Industry- Product category
- Pharmaceutical Medical Cannabis Cultivation
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Medicinal Plant Farming (Botanical/Pharmaceutical Crops) (AFAGAGAE)
Keywords
Where MedCan is headquartered
LocationHeadquarters
- HQ city
- Johannesburg
- HQ country
- South Africa
- HQ region
- Africa
Offices2 records
Markets served
MedCan business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Cannabis Flower Export: MedCan cultivates and exports pharmaceutical-grade cannabis flowers high in THC to international markets, particularly the United Kingdom. The company sells consistent, GMP-certified dried flower products to licensed pharmaceutical distributors and medical cannabis product manufacturers.
- Licensed Cultivation Products: Products sold include Isando TS 19 (19% THC) and Isando TS 24 (24% THC) dried cannabis flowers, sold in batches with Certificate of Analysis to pharmaceutical companies and licensed medical cannabis product manufacturers.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
MedCan product offering
Product offeringCore offering
MedCan cultivates and exports pharmaceutical-grade indoor medical cannabis flowers sold under the Isando brand, with two SKUs — Isando TS 19 (19% THC) and Isando TS 24 (24% THC) — both derived from the proprietary Tokoloshe Sherbet strain. The company sells dried, third-party lab-tested flower batches with Certificates of Analysis to licensed pharmaceutical distributors and medical cannabis product manufacturers, with the United Kingdom as its primary export market. All production is carried out in a SAHPRA-licensed, GACP- and GMP-certified indoor facility in Isando, South Africa.
Product overview
MedCan is a fully indoor medical cannabis cultivation company offering pharmaceutical-grade cannabis flowers. Their product portfolio centers on the Isando brand, which includes two variants: Isando TS 19 (19% THC) and Isando TS 24 (24% THC), both derived from the Tokoloshe Sherbert strain. The products are characterized by high THC content, rich terpene profiles, and consistent quality achieved through rigorous scientific cultivation processes.
Differentiator
Problem solved
Functional benefit
Brands
- Isando: A unique phenotype resulting from in-house pheno-hunting, featuring consistent high THC content for medical cannabis patients. Marketed as Isando TS 19 (19% THC) and Isando TS 24 (24% THC), both of Tokoloshe Sherbert strain.
Products and services
- Isando TS 19 Pharmaceutical-grade indoor medical cannabis flower with 19% THC content, derived from the Tokoloshe Sherbet strain developed through MedCan's in-house pheno-hunting process. Sold in batches with a Certificate of Analysis to licensed pharmaceutical distributors and medical cannabis product manufacturers, primarily in the United Kingdom.
- Isando TS 24 Pharmaceutical-grade indoor medical cannabis flower with 24% THC, <1% CBD, and >1% CBG content. Derived from the Tokoloshe Sherbet strain (Jack Herer × Ace of Spades, back-crossed with Biker Kush V2) with prominent terpenes including Myrcene, Limonene, and Linalool, featuring a sweet sugar candy aroma with subtle sandalwood undertones. Sold in batches with a Certificate of Analysis to licensed pharmaceutical distributors.
Quantifiable outcome
- 32,963 litres of rainwater harvested annually, 90% water recapture rate
- +1 more outcomes
Companies that use MedCan
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles1 record
MedCan technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
MedCan partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Cannabis Industry Council (UK)coreMedCan joined the Cannabis Industry Council in the UK, demonstrating active involvement and commitment to driving positive change in the cannabis industry. This membership provides industry advocacy, networking, and standards development participation.
- Katlehong Community GardenminorMedCan donates used growing medium (coco coir) to the Katlehong Community Garden where it is used to enrich soil, boosting water retention, drainage, and aeration for healthier, more abundant crops. This initiative enhances local food security and creates jobs.
- JNF Walter Sisulu Environmental CentreminorMedCan donates used growing medium to the JNF Walter Sisulu Environmental Centre to support their agricultural programs. The donations help train and recruit more people while enabling the centre to improve crop yields.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
MedCan competitors and assessment
Company assessmentDirect peers
- Jazz Pharmaceuticals (GW Pharmaceuticals): Through GW Pharmaceuticals, Jazz is the leading UK-based developer and supplier of prescription cannabis-based medicines (e.g., Sativex). Highly comparable to MedCan as a UK-channel medical cannabis supplier with pharmaceutical-grade standards, though Jazz/GW is much larger and focused on finished dosage forms.
- OrganiGram Holdings: Canadian medical cannabis cultivator with international distribution focus. Comparable to MedCan as an indoor pharmaceutical-grade flower producer with comparable mid-tier scale and EU export ambitions.
- Canopy Growth: Large global cannabis company with medical cannabis operations across multiple jurisdictions. Comparable to MedCan in GMP-grade medical cannabis flower production, though at significantly greater scale.
- MGC Pharmaceuticals: Australian/European medical cannabis company focused on GMP-certified cultivation and pharmaceutical distribution. Comparable to MedCan in scale, regulatory approach, and European medical channel focus.
- Aurora Cannabis: Canadian licensed producer focused on medical cannabis cultivation and international pharmaceutical distribution. Comparable to MedCan in GMP-certified indoor cultivation of pharmaceutical-grade flower for medical channels.
- Khiron Life Sciences: Medical cannabis company with cultivation in Latin America and distribution focus in Europe. Comparable to MedCan in GMP-certified pharmaceutical-grade production targeting European pharmaceutical buyers.
- Tilray Brands: Global cannabis cultivator and pharmaceutical-grade product supplier with international medical cannabis distribution. Comparable to MedCan as a wholesale B2B medical cannabis producer serving regulated pharmaceutical channels across multiple geographies.
Broad incumbents
- Cresco Labs: US-based multi-state cannabis operator with a sizable medical cannabis portfolio. Comparable to MedCan in pharmaceutical-grade medical cannabis production, though primarily serving US state-licensed channels rather than international pharmaceutical export.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
MedCan social profiles
Digital presenceMedCan compliance and trust
Trust signalCompliance3 records
MedCan financial estimates
Financial estimateRevenue estimate
Valuation estimate
MedCan leadership team
Management profileNumber of profiles
Profiles9 records
MedCan funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MedCan M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MedCan
What does MedCan do?
MedCan cultivates and exports pharmaceutical-grade indoor medical cannabis flowers sold under the Isando brand, with two SKUs — Isando TS 19 (19% THC) and Isando TS 24 (24% THC) — both derived from the proprietary Tokoloshe Sherbet strain. The company sells dried, third-party lab-tested flower batches with Certificates of Analysis to licensed pharmaceutical distributors and medical cannabis product manufacturers, with the United Kingdom as its primary export market. All production is carried out in a SAHPRA-licensed, GACP- and GMP-certified indoor facility in Isando, South Africa.
Is MedCan a public or private company?
MedCan is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MedCan founded?
MedCan was founded in 2015. It employs 11 to 50 people.
Where is MedCan based?
MedCan is headquartered in Johannesburg, South Africa, in the Africa region.
How does MedCan make money?
Two revenue lines are on record. Pharmaceutical Cannabis Flower Export is the primary driver. The others are licensed Cultivation Products.
Who are MedCan's main competitors?
Direct peers on record are Jazz Pharmaceuticals (GW Pharmaceuticals), OrganiGram Holdings, Canopy Growth, MGC Pharmaceuticals, Aurora Cannabis, Khiron Life Sciences and Tilray Brands. Cresco Labs is listed as a broad incumbent.
Does MedCan have an API?
No public API is recorded for MedCan.
What industry is MedCan in?
MedCan's product category is Pharmaceutical Medical Cannabis Cultivation. Its primary akta.pro industry code is AFAGAGAE, Medicinal Plant Farming (Botanical/Pharmaceutical Crops). Its NAICS code is 325411 and its SIC code is 2833.